Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 622

Results For "US"

7106 News Found

Aster Volunteers offer free diabetes screening in India and UAE
Events | December 03, 2021

Aster Volunteers offer free diabetes screening in India and UAE

In 2019, diabetes was the ninth leading cause of death with an estimated 1.5 million deaths directly caused by diabetes, as per WHO


Unichem Labs gets ANDA approval for schizophrenia medicine
Drug Approval | December 03, 2021

Unichem Labs gets ANDA approval for schizophrenia medicine

The product will be commercialized from Unichem's Ghaziabad plant


Biocon Pharma receives ANDA approval for Mycophenolic acid
Drug Approval | December 03, 2021

Biocon Pharma receives ANDA approval for Mycophenolic acid

This further adds to Biocon’s portfolio of vertically integrated complex drug products


North America accounts for 50 % of generic pharma market
News | December 03, 2021

North America accounts for 50 % of generic pharma market

Going forward, the fastest-growing regions in the generic pharmaceuticals market will be South America and the Middle East, where growth will be at CAGRs of 10.1% and 9.4% respectively


Neuberg Diagnostics expands to North India
Diagnostic Center | December 03, 2021

Neuberg Diagnostics expands to North India

Collectively, these 10 laboratories are capable of processing about 10,000 samples in a day and deliver results within the given turnaround time


Booster dose  for those above 40
News | December 03, 2021

Booster dose for those above 40

The recommendation was made by the Indian SARS-CoV-2 Genomics Sequencing Consortium (INSACOG), a network of national testing labs set up by the government to monitor genomic variations of Covid-19


Lupin partners with TTP for soft-mist inhalation tech platform
Biotech | December 02, 2021

Lupin partners with TTP for soft-mist inhalation tech platform

Soft-mist inhalation (SMI) technology allows for delivery of inhalation drugs from a small, portable hand-held inhaler device without the use of propellants


ZyCoV-D to be initially administered in seven states
News | December 02, 2021

ZyCoV-D to be initially administered in seven states

The three doses of ZyCoV-D are to be administered 28 days apart. The vaccine was given emergency use authorisation (EUA) by the Indian drug regulator on August 20


Serum seeks DCGI approval for booster dose in India
News | December 02, 2021

Serum seeks DCGI approval for booster dose in India

The UK’s Medicine and Healthcare products Regulatory Agency has already approved the booster dose of AstraZenenca’s Covid-19 vaccine, which is administered in India


Molnupiravir, a step closer to approval in the fight against Covid-19
News | December 02, 2021

Molnupiravir, a step closer to approval in the fight against Covid-19

The U.S. FDA advisory committee voted 13-10 in favour of the oral antiviral medicine